7733 Olympus Corp.

EQS-News: Olympus Enhances Innovation Capabilities by Expanding R&D to Hyderabad, India

EQS-News: Olympus Corp. / Key word(s): Miscellaneous
Olympus Enhances Innovation Capabilities by Expanding R&D to Hyderabad, India

12.06.2024 / 14:30 CET/CEST
The issuer is solely responsible for the content of this announcement.


Olympus Enhances Innovation Capabilities by Expanding R&D to Hyderabad, India
 

fncls.ssp?fn=download2_file&code_str=016ba4a1f00817e8a3aa042e15d14dbb

Endoscopy Engineering support services in India

 

Tokyo, Japan, 12 June 2024, JCN Newswire - Olympus Corporation (Olympus), a global MedTech Company committed to making people’s lives healthier, safer and more fulfilling, today announced its strategic initiative to establish an R&D Offshore Development Center (ODC) in Hyderabad, India. This decision comes as a result of a strategic agreement with global technology company HCLTech, aimed at diversifying Olympus' innovation generation activities.

Establishing this R&D ODC in Hyderabad is part of Olympus' commitment to leverag e global R&D talents and resources driving advancements in medical technology. Hyderabad is a major metropolitan area and is known as India’s MedTech hub, providing the talent needed for research and development activities necessary for Olympus' expansion efforts.

Concurrent with the creation of the ODC, Olympus will also prepare for the establishment of Olympus’ in-house R&D center in the coming years. This center would be in addition to the company’s current R&D centers in Japan, the United States, and Europe.

The company plans to further establish its presence in the country by collaborating with AIG Hospitals, Hyderabad for joint research projects. By partnering with one of India's premier healthcare institutions, Olympus aims to leverage clinical expertise and insights to drive t he development of innovative medical solutions that address the evolving needs of patients worldwide.

Since establishing Olympus Medical Systems India Private Limited in 2009, Olympus has continued to expand its operations in India and has achieved growth with the support of its many stakeholders. These strategic initiatives not only reinforce Olympus’ commitment to advancing medical technology but also strengthen its global footprint and enhance the company’s ability to deliver impactful healthcare solutions.

 

Comment from Andre Roggan, Chief Technology Officer at Olympus

“It is with great pleasure and excitement that we announce this agreement with HCLTech, with whom we share a decade-long partnership in core engineering and R&D services. I am confident that our collaboration will enhance Olympus’ engineering capabilities and unlock new innovations that enable quality healthcare through technology.”

 

Comment from Mr. D. Sridhar Babu, Minister of Information Technology, Electronics & Communications (ITE&C) and Industries & Commerce (I&C) of the Government of Telangana

We are thrilled that Olympus Corporation, one of the world's largest medical device companies, has chosen Hyderabad for its first investment in India with an R&D center, marking a significant milestone for our city's medical devices ecosystem. With Hyderabad's robust infrastructure, strategic location, and thriving community of innovative healthcare companies, this investment is poised to be a game-changer for the medical devices sector in India. We are confident that Olympus' advanced technologies and expertise will significantly contribute to our vision of becoming a global hub for medical device innovation and manufacturing. I welcome Olympus Corporation to our ecosystem.”

 

About HCLTech

HCLTech is a global technology company, home to more than 227,000 people across 60 countries, delivering industry-leading capabilities centered around digital, engineering, cloud , and AI, powered by a broad portfolio of technology services and products. HCLTech works with clients across all major verticals, providing industry solutions for Financial Services, Manufacturing, Life Sciences and Healthcare, Technology and Services, Telecom and Media, Retail and CPG, and Public Services. Consolidated revenues as of the 12 months ending March 2024 totalled $13.3 billion. To learn how HCLTech can supercharge progress for you, visit hcltech.com.

 

About Olympus

At Olympus, we are committed to Our Purpose of making people’s lives healthier, safer and more fulfilling. As a global medical technology company, we partner with healthcare professionals to provide best-in-class solutions and services for early detection, diagnosis and minimally invasive treatment, aiming to improve patient outcomes by elevating the standard of care in targeted disease states. For more than 100 years, Olympus has pursued a goal of contributing to society by producing products designed with the purpose of delivering optimal outcomes for its customers around the world. For more information, visit olympus-global.com and follow our global X account: @Olympus_Corp.

 

Media contact:

Mail:  

 

Olympus Corp [TYO: 7733] [ADR: OLYMY] [STU: OLY1] [FRA: OLYS]



12.06.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at -news.com


1923725  12.06.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1923725&application_name=news&site_id=research_pool
EN
12/06/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Olympus Corp.

Nia Dokova
  • Nia Dokova

PSA Healthcare Products: Olympus (7733 JT) Update Post FY24 Q1 Results

With no further write-offs and the Orthopaedics business now sold, Olympus seems to be on track to become a pure medtech play. Valuations, however, remain high.

 PRESS RELEASE

EQS-News: Olympus Enhances Innovation Capabilities by Expanding R&D to...

EQS-News: Olympus Corp. / Key word(s): Miscellaneous Olympus Enhances Innovation Capabilities by Expanding R&D to Hyderabad, India 12.06.2024 / 14:30 CET/CEST The issuer is solely responsible for the content of this announcement. Olympus Enhances Innovation Capabilities by Expanding R&D to Hyderabad, India   Endoscopy Engineering support services in India   Tokyo, Japan, 12 June 2024, JCN Newswire - Olympus Corporation (Olympus), a global MedTech Company committed to making people’s lives healthier, safer and more fulfilling, today announced its strategic initiative ...

Nia Dokova
  • Nia Dokova

PSA Healthcare Products: Olympus (7733 JT) Cements FY23 as a Write-Off...

Olympus (7733 JT) seems to be leaning into the market’s acceptance that FY23 is a write-off, reporting yet more expenses for Q4. This review includes management’s comments on how the firm plans to achieve an earnings recovery in FY24.

Nia Dokova
  • Nia Dokova

PSA Health Care Equipment: Olympus (7733 JT) - FY24 Test on Clean Up O...

FY23 is proving to be a housecleaning year for Olympus, some of it undertaken proactively, such as the sale of the scientific instruments business, some of it reactively, such as recalls and write downs. Analyst Nia Dokova discusses the outlook.

Pelham Smithers
  • Pelham Smithers

PSA Healthcare: Olympus (7733 JT) – Time to Look Forward to FY24?

Asset sale gains by Olympus in FY22 made it hard for FY23 to look good anyway, but a procession of problems has turned a difficult situation into a bad one. However, with most of the issues being one-offs, a recovery in earnings is expected in FY24. With the shares down -30% from their peak, it may be time to revisit the stock.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch